Back

Role of implantable cardioverter defibrillator device therapy in patients with progressive Fabry disease

28 August 2016 (09:06 - 09:15)
Organised by:
Congress Presentation Part of: Gene and arrhythmias Genetic aspects of arrhythmias ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Daniel Oder

Wuerzburg (Germany)

9 More presentations in this session

Presentation thumbnail
Whole exome sequencing of families with atrial fibrillation - a Danish nationwide study.
Doctor L. Refsgaard (Copenhagen, DK)
Abstract
Presentation thumbnail
Age and gender related differences in corrected QT interval in children and adolescents with LQT1 and LQT2
Doctor S. Vink (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Genetic determinants of arrhythmia in dilated cardiomyopathy
Doctor U. Tayal (London, GB)
Abstract
Presentation thumbnail
Location of SCN5A mutation determines severity of phenotype and response to sodium channel blockage
Mr Y. Reckman (Zwolle, NL)
Abstract Slides Video
Presentation thumbnail
Cardiac phenotype and prognosis of patients with mutations in NKX2.5 gene
Doctor P. Maury (Toulouse, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Gene and arrhythmias

The Event

Event poster

ESC Congress 2016

28 August 2016 09:06 CET
You may be interested in
thumbnail
Congress Presentation
A challenging case of severe left ventricular hypertrophy (Fabry disease)
12 December 2025
thumbnail
Congress Session
Evolution in pacing and risk management strategies in sudden cardiac death
31 March 2025
thumbnail
Congress Session
Clinical course of specific cardiomyopathies
18 May 2025
thumbnail
Congress Presentation
Advanced electrocardiography predicts early cardiac involvement and incident arrhythmias in Fabry disease
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources